These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26214531)

  • 1. Drug augmented hepatobiliary scintigraphy for evaluation of neonatal cholestasis: what does the evidence point to?
    Sadeghi R
    Nucl Med Commun; 2015 Sep; 36(9):965. PubMed ID: 26214531
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-augmented hepatobiliary scintigraphy for evaluation of neonatal cholestasis: What does the evidence point to?
    Malik D
    Nucl Med Commun; 2015 Sep; 36(9):966. PubMed ID: 26214532
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of phenobarbitone and ursodeoxycholic acid in drug-augmented hepatobiliary scintigraphy for excluding the diagnosis of obstructive cholestasis in neonatal cholestasis syndrome.
    Malik D; Khan SH; Ali SW; Rather TA; Pakala R; Hassan MU; Yadav N; Pasupula M
    Nucl Med Commun; 2015 Aug; 36(8):827-32. PubMed ID: 25920049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid versus phenobarbital pretreatment prior to hepatobiliary scintigraphy in neonatal cholestasis: is it time for shifting gears towards a practice change?
    Basu S; Bhattacharya A
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1160-1. PubMed ID: 25687536
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatobiliary scintigraphy in segmental biliary obstruction].
    Aburano T; Kuwajima A; Ishida H; Tonami N; Hisada K; Matsudaira M
    Kaku Igaku; 1984 Apr; 21(4):311-7. PubMed ID: 6471598
    [No Abstract]   [Full Text] [Related]  

  • 6. Ursodeoxycholic acid-augmented hepatobiliary scintigraphy in the evaluation of neonatal jaundice.
    Poddar U; Bhattacharya A; Thapa BR; Mittal BR; Singh K
    J Nucl Med; 2004 Sep; 45(9):1488-92. PubMed ID: 15347715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatobiliary scintigraphy with Tc-99m-EHIDA in patients with obstructive jaundice].
    Hu YZ
    Zhonghua Wai Ke Za Zhi; 1988 Oct; 26(10):631-2, 640. PubMed ID: 3243140
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatobiliary scintigraphy in the study of neonatal hepatic cholestasis].
    Salvatori M; Valenza V; De Franco A; De Gaetano AM
    Radiol Med; 1989 Dec; 78(6):638-44. PubMed ID: 2516635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of hepatocyte extraction fraction to evaluate neonatal cholestasis.
    Tolia V; Kottamasu SR; Tabassum D; Simpson P
    Clin Nucl Med; 1999 Sep; 24(9):655-9. PubMed ID: 10478739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver and hepatobiliary scintigraphy in children.
    Padhy AK; Basu AK
    Indian Pediatr; 1982 Mar; 19(3):249-63. PubMed ID: 6754605
    [No Abstract]   [Full Text] [Related]  

  • 11. [Basic studies on the hepatobiliary scintigraphy with 123I-rose bengal (author's transl)].
    Narabayashi I; Konno K; Ito Y; Otsuka N; Muranaka A; Nagai K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1979 May; 39(5):520-7. PubMed ID: 482071
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatobiliary scintigraphy findings of a patient with polianomaly presenting with icterus.
    Koç ZP; Balci TA; Kepenek F
    BMJ Case Rep; 2011 Jul; 2011():. PubMed ID: 22689850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of hepatobiliary scintigraphy using 99mTc-pyridoxylideneisoleucine (author's transl)].
    Kashiwagi T; Kimura K; Fusamoto H; Suematsu T; Schichiri M; Kamada T; Abe H
    Nihon Shokakibyo Gakkai Zasshi; 1979 Apr; 76(4):924-33. PubMed ID: 449110
    [No Abstract]   [Full Text] [Related]  

  • 14. Findings of hepatobiliary scintigraphy and liver biopsy in Maroteaux-Lamy syndrome presenting as neonatal cholestasis.
    Arslan N; Mavi A; Kalkan S; Aydin A; Ortaç R; Büyükgebiz B; Durak H
    Pediatr Int; 2006 Oct; 48(5):498-500. PubMed ID: 16970791
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatobiliary scanning and its significance in the differential diagnosis of mechanical and hepatocellular jaundice].
    Zimácek J; Takács J; Magyar B; Bilcíková M; Kovácik M
    Vnitr Lek; 1983 Jul; 29(7):662-71. PubMed ID: 6613034
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenobarbital-enhanced hepatobiliary scintigraphy in the diagnosis of biliary atresia: two decades of experience at a tertiary center.
    Kwatra N; Shalaby-Rana E; Narayanan S; Mohan P; Ghelani S; Majd M
    Pediatr Radiol; 2013 Oct; 43(10):1365-75. PubMed ID: 23666168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The influence of ursodeoxycholic acid on hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan in chronic liver diseases].
    Hayakawa T; Katagiri K; Shiraka S; Nakai T; Takeshima A; Kawamura Y; Ohnishi H; Hoshino M; Tsukada K; Miyani M
    Nihon Shokakibyo Gakkai Zasshi; 1988 Nov; 85(11):2389-95. PubMed ID: 3221493
    [No Abstract]   [Full Text] [Related]  

  • 18. Pretreatment with ursodeoxycholic acid (UDCA) as a novel pharmacological intervention in hepatobiliary scintigraphy.
    Jeong HJ; Kim CG
    Yonsei Med J; 2005 Jun; 46(3):394-8. PubMed ID: 15988812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary scintigraphy with a new scanning agent, 99mTc-(SN)-pyridoxylidene-isoleucine.
    Aoki Y; Taniguchi K; Katsumi M
    Am J Gastroenterol; 1979 Dec; 72(6):630-7. PubMed ID: 539581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factor analysis of sequential hepatobiliary scintigraphy].
    Michalová K; Sámal M; Sůrová H; Kaláb M; Cervinka J; Petrtýl J
    Sb Lek; 1986; 88(4-5):149-54. PubMed ID: 3726433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.